Pre-Lamin A/C
Pre-Lamin A/C[edit | edit source]
Pre-Lamin A/C is a precursor protein that is processed to form Lamin A and Lamin C, which are essential components of the nuclear lamina, a dense fibrillar network inside the nucleus of most cells. These proteins are encoded by the LMNA gene and play a critical role in maintaining the structural integrity of the nucleus, regulating gene expression, and facilitating DNA replication and repair.
Structure[edit | edit source]
Pre-Lamin A/C is initially synthesized as a single polypeptide chain. The LMNA gene undergoes alternative splicing to produce two main isoforms: Lamin A and Lamin C. Pre-Lamin A contains a C-terminal CAAX motif, which undergoes a series of post-translational modifications, including farnesylation, proteolytic cleavage, and methylation, to become mature Lamin A. Lamin C, on the other hand, lacks the CAAX motif and does not undergo these modifications.
Function[edit | edit source]
Pre-Lamin A/C, through its mature forms, Lamin A and Lamin C, contributes to the mechanical stability of the nucleus. It interacts with other nuclear envelope proteins and chromatin, influencing nuclear shape and size. Lamin A/C is also involved in the regulation of gene expression by interacting with transcription factors and chromatin-modifying complexes.
Clinical Significance[edit | edit source]
Mutations in the LMNA gene can lead to a group of disorders known as laminopathies. These include Hutchinson-Gilford Progeria Syndrome, Emery-Dreifuss Muscular Dystrophy, and Dilated Cardiomyopathy. These conditions are characterized by defects in nuclear structure and function, leading to a wide range of clinical manifestations.
Processing of Pre-Lamin A[edit | edit source]
The processing of Pre-Lamin A involves several steps:
1. Farnesylation: Addition of a farnesyl group to the cysteine residue in the CAAX motif. 2. Proteolytic Cleavage: Removal of the last three amino acids (AAX) by the enzyme ZMPSTE24. 3. Methylation: Methylation of the farnesylated cysteine. 4. Second Proteolytic Cleavage: Removal of the farnesylated cysteine by ZMPSTE24, resulting in mature Lamin A.
Defects in this processing pathway, particularly mutations affecting ZMPSTE24, can lead to the accumulation of farnesylated Pre-Lamin A, which is toxic to cells and contributes to disease pathogenesis.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD